Welch Capital Partners LLC NY Cuts Stake in Humana Inc. (NYSE:HUM)

Welch Capital Partners LLC NY decreased its position in Humana Inc. (NYSE:HUM) by 1.1% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 34,935 shares of the insurance provider’s stock after selling 380 shares during the quarter. Humana makes up 4.3% of Welch Capital Partners LLC NY’s investment portfolio, making the stock its 5th largest position. Welch Capital Partners LLC NY’s holdings in Humana were worth $15,994,000 at the end of the most recent quarter.

A number of other institutional investors also recently modified their holdings of the company. Dorsey & Whitney Trust CO LLC raised its position in shares of Humana by 2.6% in the 3rd quarter. Dorsey & Whitney Trust CO LLC now owns 817 shares of the insurance provider’s stock worth $397,000 after acquiring an additional 21 shares in the last quarter. First Financial Corp IN raised its holdings in Humana by 7.2% in the fourth quarter. First Financial Corp IN now owns 343 shares of the insurance provider’s stock worth $157,000 after purchasing an additional 23 shares in the last quarter. PDS Planning Inc lifted its position in Humana by 4.1% during the third quarter. PDS Planning Inc now owns 609 shares of the insurance provider’s stock valued at $296,000 after buying an additional 24 shares during the period. First Trust Direct Indexing L.P. boosted its holdings in shares of Humana by 0.8% during the 3rd quarter. First Trust Direct Indexing L.P. now owns 2,926 shares of the insurance provider’s stock valued at $1,424,000 after buying an additional 24 shares in the last quarter. Finally, Nvwm LLC boosted its holdings in shares of Humana by 41.0% during the 3rd quarter. Nvwm LLC now owns 86 shares of the insurance provider’s stock valued at $42,000 after buying an additional 25 shares in the last quarter. 92.38% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several research firms have recently issued reports on HUM. Truist Financial reiterated a “hold” rating and set a $550.00 target price on shares of Humana in a report on Friday, January 19th. Oppenheimer dropped their target price on Humana from $415.00 to $370.00 and set an “outperform” rating on the stock in a report on Thursday, April 25th. Argus downgraded Humana from a “buy” rating to a “hold” rating in a report on Wednesday, March 13th. Cantor Fitzgerald lowered their price target on Humana from $391.00 to $360.00 and set a “neutral” rating for the company in a research report on Thursday, April 25th. Finally, Stephens cut their price objective on shares of Humana from $550.00 to $430.00 and set an “overweight” rating on the stock in a research report on Friday, January 26th. Eleven equities research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus target price of $424.50.

Insider Transactions at Humana

In related news, Director Jorge S. Mesquita acquired 545 shares of Humana stock in a transaction dated Tuesday, February 20th. The stock was purchased at an average cost of $367.09 per share, for a total transaction of $200,064.05. Following the purchase, the director now directly owns 2,578 shares of the company’s stock, valued at approximately $946,358.02. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 0.29% of the company’s stock.

Humana Stock Performance

HUM traded down $1.06 during mid-day trading on Tuesday, reaching $302.09. 1,565,451 shares of the company traded hands, compared to its average volume of 1,990,495. The stock has a market capitalization of $36.40 billion, a P/E ratio of 19.03, a P/E/G ratio of 1.79 and a beta of 0.45. Humana Inc. has a 52-week low of $299.23 and a 52-week high of $541.21. The company has a quick ratio of 1.67, a current ratio of 1.67 and a debt-to-equity ratio of 0.77. The company’s fifty day moving average price is $326.86 and its 200-day moving average price is $393.28.

Humana (NYSE:HUM) last announced its earnings results on Wednesday, April 24th. The insurance provider reported $7.23 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.12 by $1.11. Humana had a return on equity of 17.76% and a net margin of 1.82%. The business had revenue of $29.61 billion for the quarter, compared to analysts’ expectations of $28.52 billion. During the same period last year, the firm posted $9.38 earnings per share. The business’s revenue for the quarter was up 10.7% on a year-over-year basis. On average, sell-side analysts expect that Humana Inc. will post 16.08 EPS for the current year.

Humana Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, July 26th. Shareholders of record on Friday, June 28th will be given a $0.885 dividend. The ex-dividend date of this dividend is Friday, June 28th. This represents a $3.54 annualized dividend and a yield of 1.17%. Humana’s payout ratio is presently 22.04%.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.